Our Coalition

About the Alliance

A diverse coalition of scientists, advocates, and healthcare leaders working to advance access to life-saving monoclonal antibody therapies.

Purpose

Our Mission

We champion the innovation, development, and equitable access to monoclonal antibody therapies that can save lives and reduce the burden of infectious disease.

The Antibody Innovation Alliance brings together diverse voices from across the biomedical ecosystem — from cutting-edge research labs to patient advocacy groups, from healthcare providers to policy makers.

Our shared belief: that mAbs represent a transformative advance in infectious disease prevention and treatment, one that deserves broader awareness, understanding, and support.

We work to ensure that this powerful tool reaches the people who need it most, when they need it most.

Viral and molecular structures representing infectious diseases and immune response

Core Values

What We Stand For

Three foundational pillars guide our advocacy and drive our mission forward.

Innovation

Supporting continued research and development to advance mAb technology, improve efficacy, and expand therapeutic applications across more diseases.

Access

Advocating for policies and systems that ensure equitable access to mAb therapies regardless of geography, socioeconomic status, or insurance coverage.

Education

Raising awareness about mAb science, safety, and efficacy among patients, providers, and policymakers to drive informed decision-making.

Community

Our Coalition

The Alliance brings together stakeholders across the biomedical ecosystem.

Biotech Companies

Leading developers of next-generation antibody therapies.

Innovative mAb developers
Platform technology companies
Manufacturing specialists
Emerging biotech startups

Research Institutions

Academic and medical centers advancing antibody science.

Leading research universities
Government research institutes
Clinical trial networks
International collaborations

Patient Advocates

Organizations representing communities most in need.

Immunocompromised patient groups
Elderly care advocates
Pediatric disease organizations
Global health NGOs

Healthcare Providers

Clinicians on the front lines of patient care.

Infectious disease specialists
Emergency medicine physicians
Nurse practitioners
Public health officials